Clinical trials for potential COVID-19 vaccines need to include a more diverse roster of participants
Clinical Research Pathways
Clinical Research Pathways, an Atlanta-based non-profit, announces a grant to Wellstar Health System designed to increase diversity in oncology-related clinical trials
Clinical Research Pathways, a non-profit that advocates for increasing diversity in clinical research and expanding access to experimental drugs, biologics and medical devices, has added a new member to its board of directors.
Nonprofit Clinical Research Pathways announces two new members of its Board of Directors, from the Atlanta area
Under the three-year program, minority physicians will be recruited to conduct clinical trials—research studies that prospectively assign human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. The goal is to encourage more minority patients to participate in clinical trials by taking trials directly to minority patient populations.
A new guide to helping patients understand two important options when they face serious or life-threatening illnesses: clinical trials and FDA's expanded access program to gain access to experimental/investigational drugs.
Clinical Research Pathways has launched an effort to learn what information and other resources physicians need to seek access to experimental drugs for desperately ill or terminal patients, using the expanded access program.
Two new directors add expertise to the Board for this independent public charity focused on diversity in research and expanded access to experimental drugs.
Name change for WCG Foundation